Tavo klinika, UAB - financials and debts

Company age: 30 y. 0 mo.

Update

Tavo klinika - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 517,334 1,138,599 1,087,896 1,353,578 1,653,958 1,914,237 2,356,254 2,522,584
Profit before tax 105,625 217,684 94,419 84,069 205,522 193,274 124,776 191,059
Net profit 95,264 202,881 88,858 71,036 174,814 162,282 89,207 156,761
Equity 390,981 593,862 682,720 668,756 773,570 895,852 985,059 1,141,820
Liabilities 823,127 750,080 741,619 626,084 545,888 944,091 983,764 811,363
Non-current assets 1,146,802 1,217,977 1,178,416 1,073,042 988,853 1,613,911 1,829,205 1,761,182
Current assets 66,031 123,115 244,195 217,636 325,471 219,525 139,618 183,991
Total assets 1,212,833 1,341,092 1,422,611 1,290,678 1,314,324 1,833,436 1,968,823 1,945,173
Taxes paid
STI taxes - - - - - 246,480 283,059 311,550
Social insurance contributions - - - - - 232,561 273,189 309,877
Financial indicators
Revenue change y/y +88.9% +120.1% -4.5% +24.4% +22.2% +15.7% +23.1% +7.1%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 7.9% 15.1% 6.2% 5.5% 13.3% 8.9% 4.5% 8.1%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 24.4% 34.2% 13.0% 10.6% 22.6% 18.1% 9.1% 13.7%
Profit margin Net profit margin. Shows the overall profitability of the company. 18.4% 17.8% 8.2% 5.2% 10.6% 8.5% 3.8% 6.2%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 20.4% 19.1% 8.7% 6.2% 12.4% 10.1% 5.3% 7.6%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 2.1 1.3 1.1 0.9 0.7 1.1 1.0 0.7
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 34,489 37,229 30,289 35,699 42,867 50,708 64,851 68,487

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Tavo klinika - Social security debts

From To Debt, €
2022-09-16 2022-09-27 640.34
2022-08-29 2022-09-14 640.34
2022-08-23 2022-08-28 1642.34
2022-07-28 2022-08-15 1658.87
2022-07-25 2022-07-27 2660.87
2022-07-18 2022-07-24 2644.34
2022-06-28 2022-07-13 2644.34
2022-06-16 2022-06-27 3646.34
2022-06-14 2022-06-14 3512.01
2022-05-30 2022-06-13 3646.01
2022-05-17 2022-05-29 4648.01
2022-04-28 2022-05-15 4648.01
2022-04-19 2022-04-27 5650.01
2022-03-28 2022-04-13 5639.31
2022-03-16 2022-03-27 6641.31
2022-02-28 2022-03-14 6641.31
2022-02-17 2022-02-27 7643.31
2022-02-07 2022-02-10 7643.31
2022-01-31 2022-02-06 7643.33
2022-01-28 2022-01-30 7643.31
2022-01-26 2022-01-27 8645.31
2022-01-18 2022-01-25 8546.56
2021-12-30 2022-01-13 8645.31
2021-12-28 2021-12-29 8645.32
2021-12-17 2021-12-27 9647.32
2021-12-16 2021-12-16 9647.33
2021-11-29 2021-12-14 9647.32
2021-11-26 2021-11-28 10649.32
2021-11-24 2021-11-25 10735.23
2021-11-16 2021-11-23 10764.90
2021-11-05 2021-11-14 10949.39
2021-10-28 2021-11-04 10949.38
2021-10-27 2021-10-27 11951.38
2021-10-18 2021-10-26 11955.78
2021-09-16 2021-10-14 11951.38

Tavo klinika - VMI tax arrears

From To Overdue, €
2026-05-15 2026-05-20 11.47
2026-01-29 2026-01-30 0.55
2025-11-28 2025-12-30 0.06
2025-11-25 2025-11-25 0.22
2025-11-24 2025-11-24 42.63
2025-11-22 2025-11-23 31.29
2025-11-21 2025-11-21 2078.0
2025-02-15 2025-02-16 206.76

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Tavo klinika, UAB (code 123726527) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company generated revenue of €2.52M, up 7.1% year on year and 31.8% over two years. Net profit reached €156.8K, compared with €89.2K in 2024 and €162.3K in 2023, showing a recovery after the lower profitability seen in 2024. The 2025 profit margin was 6.2%, above the 3.8% recorded in 2024 but below the 8.5% achieved in 2023. The balance sheet remained stable, with total assets of €1.95M, equity of €1.14M and liabilities of €811.4K. Equity represented 58.7% of assets, while debt-to-equity stood at 0.71. Asset turnover was 1.30x, indicating solid use of assets to generate revenue. Return on equity was 13.7% and return on assets 8.1%. Revenue per employee was €70.1K, and profit per employee was €4.4K.